Theravance Biopharma (TBPH) SVP Rhonda Farnum Withholds 5,667 Shares

What Happened
Rhonda Farnum, SVP, Commercial & Medical Affairs at Theravance Biopharma (TBPH), had 5,667 shares withheld to satisfy tax obligations tied to the vesting of previously granted restricted stock units. The withholding was recorded at $16.95 per share for a total value of $96,056. This was a tax-withholding/share-for-tax-payment transaction (code F), not an open-market sale or purchase.

Key Details

• Transaction date: 2026-08-20 (reported on Form 4 filed 2026-08-24). Filing is timely (filed within two business days).
• Price/value: 5,667 shares × $16.95 = $96,056 (shares withheld).
• Shares disposed: 5,667 (withheld to cover taxes).
• Shares owned after transaction: Not disclosed in the filing.
• Footnote: Shares were withheld by the issuer to satisfy tax obligations arising from RSU vesting; the transaction did not involve an open-market trade (Footnote F1).
• Transaction code: F (Payment of exercise price or tax liability).

Context
Share withholding to cover tax on vested RSUs is a routine administrative action and does not indicate a market purchase or a directional bet by the insider. Purchases or open-market sales typically provide more insight into insider sentiment than tax-withholding transactions.